Literature DB >> 17332878

The fundamental basis of inflammatory bowel disease.

Warren Strober1, Ivan Fuss, Peter Mannon.   

Abstract

Two broad hypotheses have arisen regarding the fundamental nature of the pathogenesis of inflammatory bowel diseases (IBDs, which include ulcerative colitis and Crohn disease). The first contends that primary dysregulation of the mucosal immune system leads to excessive immunologic responses to normal microflora. The second suggests that changes in the composition of gut microflora and/or deranged epithelial barrier function elicits pathologic responses from the normal mucosal immune system. Here we examine these hypotheses and conclude that IBD is indeed characterized by an abnormal mucosal immune response but that microbial factors and epithelial cell abnormalities can facilitate this response.

Entities:  

Mesh:

Year:  2007        PMID: 17332878      PMCID: PMC1804356          DOI: 10.1172/JCI30587

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  80 in total

1.  Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis.

Authors:  William H Robinson; Paulo Fontoura; Byung J Lee; Henry E Neuman de Vegvar; Jennifer Tom; Rosetta Pedotti; Carla D DiGennaro; Dennis J Mitchell; Derek Fong; Peggy P-K Ho; Pedro J Ruiz; Emanual Maverakis; David B Stevens; Claude C A Bernard; Roland Martin; Vijay K Kuchroo; Johannes M van Noort; Claude P Genain; Sandra Amor; Tomas Olsson; Paul J Utz; Hideki Garren; Lawrence Steinman
Journal:  Nat Biotechnol       Date:  2003-08-10       Impact factor: 54.908

2.  Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense.

Authors:  C L Wilson; A J Ouellette; D P Satchell; T Ayabe; Y S López-Boado; J L Stratman; S J Hultgren; L M Matrisian; W C Parks
Journal:  Science       Date:  1999-10-01       Impact factor: 47.728

3.  The nature of colitis in chronic granulomatous disease.

Authors:  Michela G Schäppi; Nigel J Klein; Keith J Lindley; Dyanne Rampling; Virpi V Smith; David Goldblatt; Peter J Milla
Journal:  J Pediatr Gastroenterol Nutr       Date:  2003-05       Impact factor: 2.839

4.  Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.

Authors:  T J Creed; M R Norman; C S J Probert; R F Harvey; I S Shaw; J Smithson; J Anderson; M Moorghen; J Gupta; N A Shepherd; C M Dayan; S D Hearing
Journal:  Aliment Pharmacol Ther       Date:  2003-07-01       Impact factor: 8.171

5.  Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice.

Authors:  Masaya Kobayashi; Mi-Na Kweon; Hirotaka Kuwata; Robert D Schreiber; Hiroshi Kiyono; Kiyoshi Takeda; Shizuo Akira
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

6.  Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease.

Authors:  A Darfeuille-Michaud; C Neut; N Barnich; E Lederman; P Di Martino; P Desreumaux; L Gambiez; B Joly; A Cortot; J F Colombel
Journal:  Gastroenterology       Date:  1998-12       Impact factor: 22.682

7.  Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis.

Authors:  Atul Sinha; Jeremy Nightingale; Kevin P West; Jorge Berlanga-Acosta; Raymond J Playford
Journal:  N Engl J Med       Date:  2003-07-24       Impact factor: 91.245

Review 8.  NODs: intracellular proteins involved in inflammation and apoptosis.

Authors:  Naohiro Inohara; Gabriel Nuñez
Journal:  Nat Rev Immunol       Date:  2003-05       Impact factor: 53.106

9.  Inducible and constitutive beta-defensins are differentially expressed in Crohn's disease and ulcerative colitis.

Authors:  Jan Wehkamp; Juergen Harder; Michael Weichenthal; Oliver Mueller; Klaus R Herrlinger; Klaus Fellermann; Jens M Schroeder; Eduard F Stange
Journal:  Inflamm Bowel Dis       Date:  2003-07       Impact factor: 5.325

10.  Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma.

Authors:  Giao Q Phan; James C Yang; Richard M Sherry; Patrick Hwu; Suzanne L Topalian; Douglas J Schwartzentruber; Nicholas P Restifo; Leah R Haworth; Claudia A Seipp; Linda J Freezer; Kathleen E Morton; Sharon A Mavroukakis; Paul H Duray; Seth M Steinberg; James P Allison; Thomas A Davis; Steven A Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-25       Impact factor: 12.779

View more
  450 in total

1.  Beta7 integrin deficiency suppresses B cell homing and attenuates chronic ileitis in SAMP1/YitFc mice.

Authors:  Gezahegn Gorfu; Jesus Rivera-Nieves; Sharon Hoang; Derek W Abbott; Keely Arbenz-Smith; David W Azar; Theresa T Pizarro; Fabio Cominelli; Marcia McDuffie; Klaus Ley
Journal:  J Immunol       Date:  2010-10-06       Impact factor: 5.422

2.  An old herbal medicine with a potentially new therapeutic application in inflammatory bowel disease.

Authors:  Richard Li; Philip Alex; Mei Ye; Ting Zhang; Ling Liu; Xuhang Li
Journal:  Int J Clin Exp Med       Date:  2011-10-29

3.  Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages.

Authors:  Gabriela Schiechl; Bernhard Bauer; Ivan Fuss; Sven A Lang; Christian Moser; Petra Ruemmele; Stefan Rose-John; Markus F Neurath; Edward K Geissler; Hans-Jürgen Schlitt; Warren Strober; Stefan Fichtner-Feigl
Journal:  J Clin Invest       Date:  2011-04-25       Impact factor: 14.808

4.  Intestinal CX3C chemokine receptor 1(high) (CX3CR1(high)) myeloid cells prevent T-cell-dependent colitis.

Authors:  Hisako Kayama; Yoshiyasu Ueda; Yukihisa Sawa; Seong Gyu Jeon; Ji Su Ma; Ryu Okumura; Atsuko Kubo; Masaru Ishii; Taku Okazaki; Masaaki Murakami; Masahiro Yamamoto; Hideo Yagita; Kiyoshi Takeda
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-07       Impact factor: 11.205

5.  Structural shifts of fecal microbial communities in rats with acute rejection after liver transplantation.

Authors:  Yirui Xie; Zhuanbo Luo; Zhengfeng Li; Min Deng; Hao Liu; Biao Zhu; Bing Ruan; Lanjuan Li
Journal:  Microb Ecol       Date:  2012-03-21       Impact factor: 4.552

6.  There's a goat behind door number 3: from Monty Hall to medicine.

Authors:  David J Friedman; Laurence A Turka; Simon C Robson
Journal:  J Clin Invest       Date:  2011-10       Impact factor: 14.808

Review 7.  Crohn disease: a current perspective on genetics, autophagy and immunity.

Authors:  Thaddeus S Stappenbeck; John D Rioux; Atsushi Mizoguchi; Tatsuya Saitoh; Alan Huett; Arlette Darfeuille-Michaud; Tom Wileman; Noboru Mizushima; Simon Carding; Shizuo Akira; Miles Parkes; Ramnik J Xavier
Journal:  Autophagy       Date:  2011-04-01       Impact factor: 16.016

8.  Neuregulin-4 is a survival factor for colon epithelial cells both in culture and in vivo.

Authors:  Jessica K Bernard; Sean P McCann; Vrinda Bhardwaj; Mary K Washington; Mark R Frey
Journal:  J Biol Chem       Date:  2012-10-02       Impact factor: 5.157

9.  The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis.

Authors:  Grace Y Chen; Michael H Shaw; Gloria Redondo; Gabriel Núñez
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

Review 10.  A Molecular Link Between Interleukin 22 and Intestinal Mucosal Wound Healing.

Authors:  Xiaoyan Sun; Laura Chalmers; Xiaobing Fu; Min Zhao
Journal:  Adv Wound Care (New Rochelle)       Date:  2012-12       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.